Financhill
Back

Arcturus Therapeutics Holdings 10K Form

Sell
43

ARCT
Arcturus Therapeutics Holdings

Last Price:
22.91
Seasonality Move:
3.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive ARCT News And Ratings

See the #1 stock for the next 7 days that we like better than ARCT

ARCT Financial Statistics

Sales & Book Value

Annual Sales: $157.75M
Cash Flow: $-5.8M
Price / Cash Flow: 65.04
Annual Sales: $9.81
Price / Book: 2.43

Profitability

EPS (TTM): -3.91000
Net Income (TTM): $-107.3M
Gross Margin: $0
Return on Equity: -37.33%
Return on Assets: -24.3%

Arcturus Therapeutics Holdings Earnings Forecast

Key Arcturus Therapeutics Holdings Financial Ratios

  • The Selling, General & Administrative Expenses for ARCT have been equal to 33.52% of Gross Profit Margin.
  • The Research & Development expenses have been 121.80% of Revenue.
  • The Interest Expense is -2.58% of Operating Income.
  • The Net Earning history of ARCT is -18.84% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 6 years.

Arcturus Therapeutics Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ARCT
CUSIP: M1492T
Website: arcturusrx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.26
Quick Ratio: 2.73

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARCT Technical Analysis vs Fundamental Analysis

Sell
43
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings a Buy or a Sell?